Reduce the cost and time it takes to conduct psychedelic studies.
Designed for academic researchers, biotech, insurance, and regulatory governance.
Navigating R&D is expensive and slow. Participant recruitment can be difficult and traditional clinical softwares are not designed for the nuances of psychedelic studies.
Our Real World Data Explorer changes that.
Real World Data provides the evidence needed to inform efficient psychedelic studies. Aggregate, derivative population data covering mental health treatments and outcomes are presented in an analytics dashboard, allowing you to segment data in real-time.
Key benefits to using Maya in your research:
Harness the power of real world data.
Real world data provides evidence for clinical efficacy and generate signals to inform further controlled study. Real world practices can directly instruct clinical pathway design, reducing current trial-and-error approaches, and accelerating safe care delivery.
Decrease costs and time.
Real world psychedelic data provides the opportunity to observe treatment practices and outcomes at a dramatically reduced cost in time and money vs running controlled studies.
Increase access to qualified study participants.
By empowering individuals with insight and clarity in their own healing journey, we can activate a global ‘army’ of qualified citizen scientists who are willing to participate in psychedelic studies.
How it works
Advanced Protocol Builder.
Build your research protocol easily using Maya’s Protocol elements ranging from individual therapeutic interventions to content elements for education during preparation and integration stages.
Insights Dashboard.
View results and calculate cohort performance in real-time through Maya’s integrated Insights Dashboard.
Participant Experience Management.
Customize and manage all communications with participant through the Maya Companion App.
Psychedelic-Specific Common Data Model.
The Maya Insights dashboard offers an unparalleled opportunity for real time analysis and preliminary investigation. All data is structured in a consistent and universal 'common data model', allowing for retroactive meta analysis and cross-study comparison.
Build Protocols
Advanced Protocol Builder.
Build your research protocol easily using Maya’s Protocol elements ranging from individual therapeutic interventions to content elements for education during preparation and integration stages.
Gain Insights
Insights Dashboard.
View results and calculate cohort performance in real-time through Maya’s integrated Insights Dashboard.
Manage
Participant Experience Management.
Customize and manage all communications with participant through the Maya Companion App.
Create
Psychedelic-Specific Common Data Model.
The Maya Insights dashboard offers an unparalleled opportunity for real time analysis and preliminary investigation. All data is structured in a consistent and universal 'common data model', allowing for retroactive meta analysis and cross-study comparison.
Reduce the cost and time it takes to conduct psychedelic studies.
Join the researcher communityKey Benefits
Analysis-ready datasets covering diverse populations
(Coming soon)
Enhanced compliance vs general registries
(Coming soon)
Faster, cheaper participant recruitment
(Coming soon)
Retained data ownership & embargoed publishing rights
(Coming soon)
Unified data modeling & analysis across recruitment sites
(Coming soon)
HIPAA-compliant & IRB-approved methodologies
(Coming soon)
Enhanced participant experience & outcomes
(Coming soon)
Co-opted press & publicity for studies
(Coming soon)
Significantly larger datasets vs controlled study
(Coming soon)
Improved compliance
(Coming soon)
Improved compliance
(Coming soon)
Supportive resources about real world evidence in research.
The following materials provide information about how real world evidence is an efficient approach to conducting biomedical research.
Read our last article
Why the Future of Psychedelic Medicine Depends on a Data Science Approach to Measuring Health Outcomes and Best Practices
Posted on
February 22, 2023
Listen our last podcast
Ismail Lourido Ali (MAPS): What Legislation in Colorado and Oregon Means for Psychedelic Practitioners
Posted on
December 15, 2022
Keep updated
Subscribe to our newsletter
By completing this form I agree with Maya PBC's terms of service and privacy policy and provide my consent to receive personalized communications from Maya PBC. I understand I can unsubscribe at any time.
